NeuBase Therapeutics, Inc.·4

Apr 1, 4:16 PM ET

Mann William Roland 4

4 · NeuBase Therapeutics, Inc. · Filed Apr 1, 2022

Insider Transaction Report

Form 4
Period: 2022-03-30
Transactions
  • Purchase

    Common stock

    2022-03-30$1.92/sh+6,200$11,90411,200 total

Documents

1 file
  • 4
    tm2211303-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT